Ridaforolimus (Deforolimus)

ridaforolimus · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ridaforolimus (Deforolimus), covering 2015-04-29 to 2015-04-29. Get the full timeline:

Most recent: Clinical Trial Update: Ridaforolimus in Patients With Hepatic Insufficiency (MK-8669-046) [Phase 1]